Oscotec to Present Kidney Failure Treatment Candidate at World Congress of Nephrology in Japan
Oscotec announced on the 23rd that it will present animal-model proof-of-concept results for a new drug candidate series, the OCT-648 program, at the...
Biowatch
Alteogen to Present Subcutaneous ADC Formulation Research at International Forum in June
Alteogen announced on the 23rd that it will present research results regarding subcutaneous dosing for antibody-drug conjugate therapies at the...
HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?
HK inno.N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s...
Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation
Celltrion announced on March 20, 2026, that it has received additional approval from Health Canada for the autoinjector...
A Single Cancer Shot: Local Injection Triggers Systemic Tumor Disappearance
For decades, one immuno-oncology strategy has held immense promise while repeatedly falling short: the use of CD40...
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation
Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...
Kyungbo Pharmaceutical Passes U.S. FDA On-Site Inspection at Asan Plant
Kyungbo Pharmaceutical announced on the 18th that it passed an on-site manufacturing inspection by the U. S.
Celltrion: “Zymfentra prescriptions surging in the U.S.… growth is accelerating in earnest”
Celltrion’s subcutaneous formulation for autoimmune diseases, “Zymfentra,” which launched in the United States, has...
Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?
Huwons Global's subsidiary Huwons Lab is challenging the formulation change platform business that converts intravenous...
Hanmi Pharmaceutical, CEO Park Jae-hyun Steps Down: Hwang Sang-yeon Appointed as New CEO Candidate
Hanmi Science is replacing CEO Park Jae-hyun of its subsidiary Hanmi Pharmaceutical and forming a new board of...